Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancerBidyadhar Sethy(Taipei Medical University), Jing‐Ping Liou(Taipei Medical University)APOPTOSISOctober 12, 202410.1007/s10495-024-02023-7Cited by 9SaveCiteExport RISWatch citationsRelated PapersCorrection: Anticancer Activity of MPT0E028, a Novel Potent Histone Deacetylase Inhibitor, in Human Colorectal Cancer HCT116 Cells In Vitro and In Vivo|PLoS ONE|2012|1Quinoline-5,8-Dione CDC25 Inhibitors: Potent Anti-Cancer Agents in Leukemia and Patient-Derived Colorectal Organoids|Research Square|2025|0